Análise de Marcha

veículo de difusão de informações em análise de marcha, reabilitação e biomecânica, captura de movimento para produções industriais
clinical gait analysis, rehabilitation and biomechanics, industrial "motion capture" (MoCap)



Accreditation and Operating Standards for CGA

(AU)
The Royal Children’s Hospital:


The Hugh Williamson Gait Analysis Laboratory is named in recognition of the significant grant that the Hugh Williamson Foundation gave to the Royal Children's Hospital to establish the first gait analysis laboratory in Australia especially for children. The Hugh Williamson Gait Laboratory was first opened on the 19th June 1995 and was funded in its first year through the Hugh Williamson Foundation Grants. Since June 1998, the laboratory has been funded by the Victorian Government.

  • Functional Mobility Scale (FMS)
    • Escala de Mobilidade Funcional - The Functional Mobility Scale (2ª versão).
    Para crianças de 4 a 18 anos com paralisia cerebral.



(EU)
MD-Paedigree:

  • Model-Driven Paediatric European Digital Repository

    • MD-Paedigree represents a clinically-driven and strongly VPH-rooted project, where 7 world-renowned clinical centres of excellence pursue improved interoperability of paediatric biomedical information, data and knowledge by developing together a set of reusable and adaptable multi-scale models for more predictive, individualised, effective and safer paediatric healthcare, being scientifically and technologically supported by one of the leading industrial actors in medical applications in Europe operating in conjunction with highly qualified SMEs and some of the most experienced research partners in the VPH community.

    MD-Paedigree's goals therefore are to:
    ■integrate and share highly heterogeneous biomedical information, data and knowledge, using best practices from the biomedical semantic Web,
    ■develop holistic search strategies to seamlessly navigate through and manage the integrative
    model-driven infostructure and digital repository
    ■jointly develop reusable, adaptable and composable multi-scale VPH workflow models,
    ■support evidence-based translational medicine at the point of care, and
    ■ultimately facilitate collaborations within the VPH community.

  • Public Deliverables (PER WP)
  • D6.1
    • CGA standard Protocol
  • D6.2
    • A standard protocol of clinical gait analysis is described based on a representative inventory along

  • A European consensus protocol for clinical gait analysis
    • M. van der Krogt, M. Goudriaan, M. Petrarca, A. Balemans, M. Piening, G. Vasco, E. Castelli,
    K. Desloovere, J. Harlaar.
    European Society for Movement Analysis in Adults and Children (ESMAC) 2014.

    ResearchGate GmbH

    "The purpose of this protocol is to achieve uniformity of the execution of gait analyses among the partners of the project, and other centres that wish to follow the same standards. This uniformity allows for standardized data sharing in the European database set up within the MD-Paedigree project."



(FR)
SOFAMEA:


La SOFAMEA (Société Francophone d'Analyse du Mouvement chez l'Enfant et l'Adulte) a pour but de promouvoir la recherche dans le domaine de l'analyse de mouvement chez l'enfant et l'adulte sous différents aspects, qu'ils soient cliniques, sportifs ou autres.
En ce sens, la SOFAMEA regroupe des professionnels du milieu médical (chirurgiens, médecins MPR,...), paramédical (kinésithérapeutes, podologues,...) et de l'ingénierie. L'échange est ainsi au coeur de cette société pluridisciplinaire.


(IE/UK)
Clinical Movement Analysis Society of UK and Ireland:


CMAS was formed to encourage professional interaction, develop and monitor professional standards and training and to stimulate and advance scientific knowledge in the fields of clinical motion analysis.

■Standards Repository

■Biomech-L (10/22/2019): European Clinical Practice Guideline for Gait Analysis - Survey - Standard

"The ESMAC board will establish a European Clinical Practice Guideline for Gait Analysis. The purpose of this action will be to: improve the quality of clinical gait analysis (CGA), assure transparency of data collection and data interpretation, facilitate data sharing, promote CGA as a clinical tool, facilitate insurance reimbursement for CGA, and facilitate the tasks management of gait lab. We propose 2-year project to achieve this goal using a modified Delphi process that includes experts of CGA (clinicians, engineers, scientists, lab technicians and industry experts). The guideline will be published at the end of the project according to the AGREE recommendations. All contributors will be listed as co-authors. This project will be based on the work already done by national societies (CMAS, SIAMOC, SOFAMEA, SMALLL, GAMMA). For instance, the most advanced works are the CMAS Standards (Guide to Accreditation) and the SIAMOC paper (Benedetti et al., 2017).

The first step of this project is to define the scope of the European Clinical Practice Guideline for Gait Analysis and to identify experts of CGA interested to participate. We will appreciate if you can complete this very brief survey (should only take 5-10 minutes) and share it with colleagues. The deadline to answer is November 30th.

Standard of clinical gait analysis

Thank you very much!

Stéphane ARMAND
For the Standard group of ESMAC
ESMAC Board member"


(IT)
SIAMOC - Società Italiana di Analisi del Movimento in Clinica:


The Italian Society of Clinical Movement Analysis was funded in Pisa (Italy) on June the 11th 1999.
The mission of the Society is to foster the study and the clinical application of movement analysis methods, in order to improve the functional evaluation of motor disorders, to enhance the efficacy of the treatments through a quantitative analysis of data and a more focussed treatment planning, to quantify the results of current therapies.

  • SIAMOC position paper on gait analysis in clinical practice
    • SIAMOC position paper on gait analysis in clinical practice: General requirements, methods and appropriateness. Results of an Italian consensus conference.

    Gait & Posture 58 (2017) 252–26 (full open access)

    "Abstract

    Gait analysis is recognized as a useful assessment tool in the field of human movement research. However, doubts remain on its real effectiveness as a clinical tool, i.e. on its capability to change the diagnostic-therapeutic practice. In particular, the conditions in which evidence of a favorable cost-benefit ratio is found and the methodology for properly conducting and interpreting the exam are not identified clearly.

    To provide guidelines for the use of Gait Analysis in the context of rehabilitation medicine, SIAMOC (the Italian Society of Clinical Movement Analysis) promoted a National Consensus Conference which was held in Bologna on September 14th, 2013. The resulting recommendations were the result of a three-stage process entailing i) the preparation of working documents on specific open issues, ii) the holding of the consensus meeting, and iii) the drafting of consensus statements by an external Jury. The statements were formulated based on scientific evidence or experts’ opinion, when the quality/quantity of the relevant literature was deemed insufficient.

    The aim of this work is to disseminate the consensus statements. These are divided into 13 questions grouped in three areas of interest: 1) General requirements and management, 2) Methodological and instrumental issues, and 3) Scientific evidence and clinical appropriateness.

    SIAMOC hopes that this document will contribute to improve clinical practice and help promoting further research in the field."



(USA)
American Society for Testing and Materials
ASTM International:


Standard Test Method for Evaluating the Performance of Optical Tracking Systems that Measure Six Degrees of Freedom (6DOF) Pose

"1. Scope

1.1 Purpose—This test method presents metrics and procedures for measuring, analyzing, and reporting the relative pose error of optical tracking systems that compute the pose (that is, position and orientation) of a rigid object while the object is moving.

1.2 Usage—System vendors may use this test method to determine the performance of their Six Degrees of Freedom (6 DOF) optical tracking system which measures pose. This test method also provides a uniform way to report the measurement errors and measurement capability of the system. System users may use this test method to verify that the system’s performance is within the user’s specific requirements and within the system’s rated performance.

1.3 Test Location—The procedures defined in this standard shall be performed in a facility in which the environmental conditions are within the optical tracking system’s rated conditions.

1.4 Test Volume—This standard shall be used for testing an optical tracking system working volumes of 3000 mm long by 2000 mm wide by 2000 mm high, 6000 mm long by 4000 mm wide by 2000 mm high, or 12 000 mm long by 8000 mm wide by 2000 mm high.

1.5 Units—The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.

1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use."


Commission for Motion Laboratory Accreditation, Inc.:


CMLA is a nonprofit organization established and operated to enhance the clinical care of persons with disorders of human motion by evaluating and accrediting clinical motion laboratories by a set of standard criteria.




Standard Assessment of Motion System Accuracy:


The GCMAS Standards Committee has proposed a protocol for quantifying the accuracy of a motion analysis system (i.e., how accurate the system is at locating markers). This protocol is intended to test video-based systems that employ reflective markers, though it is possible that it could be used to test systems with active markers as well. SAMSA uses a simple device based on a earlier design used by Jim Richards to compare motion systems.




Electromyography System: FDA 510(k)
U.S. Food and Drug Administration

Regulation Number: 890.1375

Subpart B--Physical Medicine Diagnostic Devices
Sec. 890.1375 Diagnostic electromyograph.

(a)Identification. A diagnostic electromyograph is a device intended for medical purposes, such as to monitor and display the bioelectric signals produced by muscles, to stimulate peripheral nerves, and to monitor and display the electrical activity produced by nerves, for the diagnosis and prognosis of neuromuscular disease.
(b)Classification. Class II (performance standards).

Regulation Number: 882.5050

Subpart F--Neurological Therapeutic Devices
Sec. 882.5050 Biofeedback device.

(a)Identification. A biofeedback device is an instrument that provides a visual or auditory signal corresponding to the status of one or more of a patient's physiological parameters (e.g., brain alpha wave activity, muscle activity, skin temperature, etc.) so that the patient can control voluntarily these physiological parameters.
(b)Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter when it is a prescription battery powered device that is indicated for relaxation training and muscle reeducation and prescription use, subject to 882.9.


Brasil
Modelo de Banco de Dados para Exames de Marcha:

  • Exemplo
    • (1) Cadastro do Paciente, (2) Histórico, (3) Biomecânica, (4) Exame Físico